After a down year for M&A activity in the biotech industry, 2021 is expected to see greater deal volume – and the four biotechs highlighted in today’s article could be among the takeover targets. And even if they aren’t bought out, the author sees them as attractive entities on a standalone basis. For these four biotech stocks, CLICK HERE.
Bought Out Or Standalone, These 4 Potential Biotech Takeover Targets Are Attractive Picks
- by RobH
![](https://www.hotstockanalyst.com/wp-content/uploads/2021/05/2021-05-16-21_52_57-Window.png)
Tags:2021 Biotech IndustryAttractive Stock PicksBiotech SectorBiotech StockBiotech Stock PicksDeal VolumeInvestingInvestorM&A ActivityStock MarketTakeover Targets